Skip to main content

MISSION

ABION is a pharmaceutical biotech company dedicated to the development of innovative New drugs,
driven by a mission to solve the pressing issue of cancer, a threat to human survival.

We are dedicated to research and development for the ultimate well-being of mankind

On behalf of our entire team, I extend my heartfelt gratitude to all of you who are always committed and supportive of what we do at ABION.

With an endless dedication to R&D, ABION is moving forward with the mission to find and make possible key new drugs that can contribute to the well-being of present and future mankind.

Through strong partnerships with other leading domestic and foreign biopharmaceutical entities, we will develop innovative drugs recognized in global pharmaceutical markets and focus our efforts on improving the quality of life for patients suffering from rare and incurable diseases through successful clinical trials.

Therefore, we ask that you support us at ABION to help us become a global innovator of tomorrow’s drugs.

CEO, Shin Young Khee

About ABION VISION

ABION, Biotechnology Company, Pioneering Excellence

ABION, a global precision oncology Biotech company

Integrity Drives Us

At ABION, integrity is paramount. We prioritize data integrity, ensuring our medicines are developed based solely on reliable data.

Professionalism Defines Us

Professionalism is central to our approach. Our R&D experts shine, driving professionalism in every aspect of our work.

Innovation Fuels Us

Innovation is our engine. We relentlessly develop new bio-pharmaceutical drugs, pushing the boundaries of what’s possible.

Sustainability Guides Us

Sustainability is key. We’re committed to socially responsible, sustainable practices in research, development, and growth.

About ABION R&D STRATEGY

ABION‘s business strategy consists of four Pillars, each R&D pipeline carried out according to this strategy.

Target-oriented
Approach

Deep-dive
Research

Commercial
Value-boost

Proactive
Licensing-out